Preclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosis

ATTR amyloidosis is a systemic, debilitating and fatal disease caused by transthyretin (TTR) amyloid accumulation. RNA interference (RNAi) is a clinically validated technology that may be a promising approach to the treatment of ATTR amyloidosis. The vast majority of TTR, the soluble precursor of TT...

Descripción completa

Detalles Bibliográficos
Autores principales: Butler, James S., Chan, Amy, Costelha, Susete, Fishman, Shannon, Willoughby, Jennifer L. S., Borland, Todd D., Milstein, Stuart, Foster, Donald J., Gonçalves, Paula, Chen, Qingmin, Qin, June, Bettencourt, Brian R., Sah, Dinah W., Alvarez, Rene, Rajeev, Kallanthottathil G., Manoharan, Muthiah, Fitzgerald, Kevin, Meyers, Rachel E., Nochur, Saraswathy V., Saraiva, Maria J., Zimmermann, Tracy S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898164/
https://www.ncbi.nlm.nih.gov/pubmed/27033334
http://dx.doi.org/10.3109/13506129.2016.1160882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898164/
https://www.ncbi.nlm.nih.gov/pubmed/27033334
http://dx.doi.org/10.3109/13506129.2016.1160882

Ejemplares similares